Showing results (81-90 of 6,403) with videos related to
Sort By:
Pageof 641
Primary Dental Care : Journal of the Faculty of General Dental Practitioners (UK)|July 10, 1998
Biocompatibility of dentine-bonding agents. 2. Pulpal considerationsA SantiniHematology. American Society of Hematology. Education Program|December 4, 2016
Treatment of low-risk myelodysplastic syndromesValeria SantiniAnnales Pharmaceutiques Francaises|January 1, 1994
[International harmonization of regular requirements for the registration of drugs: necessity, frena limitations]C SantiniSeminars in Hematology|October 20, 2012
Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietinsValeria SantiniHematology. American Society of Hematology. Education Program|December 13, 2012
Novel therapeutic strategies: hypomethylating agents and beyondValeria SantiniOmega|September 28, 2020
Optimising the assignment of swabs and reagent for PCR testing during a viral epidemicAlberto SantiniClinical Lymphoma, Myeloma & Leukemia|August 2, 2017
First-line Therapeutic Strategies for Myelodysplastic SyndromesValeria SantiniClinical Lymphoma, Myeloma & Leukemia|June 17, 2018
Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions: Myelodysplastic SyndromesValeria SantiniPrimary Dental Care : Journal of the Faculty of General Dental Practitioners (UK)|April 4, 1998
Biocompatibility of dentine-bonding agents. 1. Factors associated with functionA SantiniMinerva Cardioangiologica|November 24, 2018
Update on cardiac implantable electronic devices: from the injectable loop recorder to the leadless pacemaker, to the subcutaneous defibrillatorMassimo Santini, Luca Santini, Stefania A Di FuscoPageof 641